2008 annual financial data
Silence Therapeutics 2008 Operating margin
Silence Therapeutics 2008 operating margin with verified reported values.
Direct answer
Operating margin was -352.74%.
Operating income was -7,792,000 GBP and net income was -7,435,000 GBP.
Operating cash flow was -6,981,700 GBP.
Get free Silence Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,209,000 GBP
- Operating income
- -7,792,000 GBP
- Net income
- -7,435,000 GBP
- Operating cash flow
- -6,981,700 GBP